Cogent Biosciences Inc (COGT)

02:51 AM

Is There Enough Volume to Lift Cogent Biosciences Inc.July 2025 Big Picture & Comprehensive Market Scan Insights - thegnnews.com

02:51 AM

Aug 13, 2025

Wedbush Lowers Earnings Estimates for Cogent Biosciences - MarketBeat

Aug 13, 2025

Aug 13, 2025

Leerink Partnrs Has Pessimistic Outlook of COGT Q3 Earnings - MarketBeat

Aug 13, 2025

Aug 12, 2025

Cogent Biosciences Announces Participation in the Jefferies Global Healthcare Conference - The Globe and Mail

Aug 12, 2025

Aug 12, 2025

Cogent Biosciences Reports First Quarter 2025 Financial Results - The Globe and Mail

Aug 12, 2025

Aug 12, 2025

Cogent Biosciences Reports Recent Business Highlights and Fourth Quarter and Full Year 2024 Financial Results - The Globe and Mail

Aug 12, 2025

Aug 12, 2025

Cogent Biosciences Secures up to $400 Million in Non-Dilutive Financing - The Globe and Mail

Aug 12, 2025

Aug 12, 2025

Cogent Biosciences to Participate in the Guggenheim Biotech Conference - The Globe and Mail

Aug 12, 2025

Aug 12, 2025

Q3 EPS Forecast for Cogent Biosciences Raised by Analyst - MarketBeat

Aug 12, 2025

Aug 12, 2025

Knott David M Jr Takes $1.28 Million Position in Cogent Biosciences, Inc. (NASDAQ:COGT) - MarketBeat

Aug 12, 2025

Aug 12, 2025

JPMorgan Chase & Co. Forecasts Strong Price Appreciation for Cogent Biosciences (NASDAQ:COGT) Stock - MarketBeat

Aug 12, 2025

Aug 11, 2025

Wedbush Reduces Earnings Estimates for Cogent Biosciences - MarketBeat

Aug 11, 2025

Aug 10, 2025

Cogent Biosciences price target lowered to $21 from $22 at H.C. Wainwright - MSN

Aug 10, 2025

Aug 10, 2025

HC Wainwright Issues Pessimistic Forecast for Cogent Biosciences (NASDAQ:COGT) Stock Price - MarketBeat

Aug 10, 2025

Aug 09, 2025

Cogent Biosciences (NASDAQ:COGT) Posts Quarterly Earnings Results, Beats Estimates By $0.02 EPS - MarketBeat

Aug 09, 2025

Aug 09, 2025

How Investors Are Reacting To Cogent Biosciences (COGT) Widening Losses in Q2 and First Half 2025 - simplywall.st

Aug 09, 2025

Aug 07, 2025

Cogent Biosciences shares fall 1.64% intraday after Cogent Communications misses Q2 net loss per share estimates. - AInvest

Aug 07, 2025

Aug 07, 2025

Cogent Biosciences Reports Increased Losses Amidst Ongoing Development - The Globe and Mail

Aug 07, 2025

Aug 06, 2025

Cogent Biosciences Reports Positive Trial Results, Updates Financial Position - AInvest

Aug 06, 2025

Aug 06, 2025

Scotiabank Maintains Cogent Biosciences(COGT.US) With Buy Rating, Maintains Target Price $17 - 富途牛牛

Aug 06, 2025

Aug 06, 2025

Needham Maintains Cogent Biosciences(COGT.US) With Hold Rating - 富途牛牛

Aug 06, 2025

Aug 06, 2025

COGT Stock Rating Maintained by HC Wainwright, Price Target Lowe - GuruFocus

Aug 06, 2025

Aug 06, 2025

Cogent Biosciences (COGT) Price Target Revised by Analyst - GuruFocus

Aug 06, 2025

Aug 06, 2025

Cogent Biosciences, Inc. (NASDAQ:COGT) Receives $18.70 Consensus Target Price from Brokerages - MarketBeat

Aug 06, 2025

Aug 06, 2025

Decoding Cogent Biosciences Inc (COGT): A Strategic SWOT Insight - GuruFocus

Aug 06, 2025

Aug 05, 2025

Promising Pipeline and Financial Stability Drive Buy Rating for Cogent Biosciences - TipRanks

Aug 05, 2025

Aug 05, 2025

Cogent Biosciences: KDJ Golden Cross and Bullish Marubozu Indicators Detected - AInvest

Aug 05, 2025

Aug 05, 2025

Cogent Biosciences Inc reports results for the quarter ended June 30Earnings Summary - TradingView

Aug 05, 2025

Aug 05, 2025

Cogent Biosciences Reports Recent Business Highlights and Secon - GuruFocus

Aug 05, 2025

Aug 05, 2025

Cogent Biosciences' Q2 net loss widens as costs mount - TradingView

Aug 05, 2025

Aug 05, 2025

Cogent Biosciences Reports Recent Business Highlights and Second Quarter 2025 Financial Results - GlobeNewswire

Aug 05, 2025

Aug 05, 2025

BRIEF-Cogent Biosciences Q2 Operating Expenses USD 75.581 Million - TradingView

Aug 05, 2025

Aug 05, 2025

Cogent's NonAdvSM Drug Trial Hits All Endpoints with 87% Response Rate, Two More Pivotal Results Coming - Stock Titan

Aug 05, 2025

Aug 04, 2025

Chart Analysts Warn of Resistance Near Cogent Biosciences Inc. PriceEntry Points For Growing Stocks Identified by Models - beatles.ru

Aug 04, 2025

Aug 03, 2025

What are analysts’ price targets for Cogent Biosciences Inc. in the next 12 monthsConsistently outstanding ROI - Jammu Links News

Aug 03, 2025

Aug 03, 2025

Should I hold or sell Cogent Biosciences Inc. stock in 2025Explosive returns - Jammu Links News

Aug 03, 2025

Aug 03, 2025

What drives Cogent Biosciences Inc. stock priceAchieve breakthrough gains with smart trades - Jammu Links News

Aug 03, 2025

Aug 03, 2025

Is it the right time to buy Cogent Biosciences Inc. stockTriple-digit returns - Jammu Links News

Aug 03, 2025

Aug 03, 2025

How strong is Cogent Biosciences Inc. company’s balance sheetGet daily updates on the hottest stocks - Jammu Links News

Aug 03, 2025

Aug 03, 2025

What is Cogent Biosciences Inc. company’s growth strategyGet real-time alerts on high-potential stocks - Jammu Links News

Aug 03, 2025

Aug 03, 2025

Y Intercept Hong Kong Ltd Sells 31,538 Shares of Cogent Biosciences, Inc. (NASDAQ:COGT) - MarketBeat

Aug 03, 2025

Aug 02, 2025

What makes Cogent Biosciences Inc. stock price move sharplyExplosive capital appreciation - Jammu Links News

Aug 02, 2025

Aug 02, 2025

What is the risk reward ratio of investing in Cogent Biosciences Inc. stockCapitalize on market trends with confidence - Jammu Links News

Aug 02, 2025

Aug 02, 2025

Cogent Biosciences (COGT) to Release Quarterly Earnings on Tuesday - MarketBeat

Aug 02, 2025

Jul 31, 2025

What institutional investors are buying Cogent Biosciences Inc. stockRetirement Planning Insights For 2025 - Jammu Links News

Jul 31, 2025

Jul 30, 2025

Published on: 2025-07-30 07:09:48 - metal.it

Jul 30, 2025